OS Fund

A coronavirus has ravaged our planet. Humanity brought to its knees by 29,829 base pairs of “bad news wrapped in a protein.” In 2014, Jeff…

Last year we announced our investment in twoXAR, a company building a next generation drug discovery platform.

There’s money to be made and lives to be saved with the tiny stuff that’s all around us.

Synthego allow any researcher to access state of the art CRISPR gene editing technology at scale.

Ginkgo Bioworks, based in Boston, has been in the headlines lately:

This article is part of a series about how OS Fund (OSF) companies are radically redefining our future by rewriting the operating systems…

This article is part of a series about how OS Fund (OSF) companies are radically redefining our future by rewriting the operating systems…

This article is part of a series about how OS Fund (OSF) companies are radically redefining our future by rewriting the operating systems…

Applying computational advances to improve drug discovery is one of the most promising areas in healthcare. Data-informed decisions can…

Hampton Creek’s Josh Tetrick is leading a new movement around the future of food. It’s science with an Iron Chef twist.

Increasing the probability that the human race will thrive.